Comparisons of the effects of second-generation antipsychotics long-acting injections on treatment retention according to severity of patient condition

firemonkey · August 26, 2018, 11:18am

ncbi.nlm.nih.gov

Comparisons of the effects of second-generation antipsychotics long-acting injections on treatment retention according to severity of patient condition.

H Suzuki, H Hibino, Y Inoue and A Takaya, Asian journal of psychiatry, Aug 2018 11

There have been no naturalistic reports in Japan clarifying the difference of second-generation antipsychotics (SGA) long-acting injections (LAIs) on treatment retention according to severity of patient condition.This study aimed to investigate the difference in treatment retention between SGA LAIs according to severity of patient condition.This study demonstrated that, although AOM patients had better rates of treatment retention compared to PP and RLAI for mild cases, the reverse was true for moderate to severe cases.Because treatment retention rates can differ for each SGA LAI based on the severity of the patient's condition.

AOM= arpiprazole once monthly.

Topic		Replies	Views
Second-generation long-acting injections anti-psychotics improve executive functions in patients with schizophrenia: a 12-month real-world study News	0	237	March 6, 2020
Long-Acting Injectable Second-Generation Antipsychotics Improve Negative Symptoms and Suicidal Ideation in Recent Diagnosed Schizophrenia Patients: A 1-Year Follow-up Pilot Study News	0	292	September 25, 2018
New Study: A comparison of the effectiveness of risperidone, haloperidol and flupentixol long-acting injections in patients with schizophrenia News	3	1052	September 24, 2015
Safety concerns associated with second-generation antipsychotic long-acting injection treatment. A systematic update News	4	663	July 5, 2017
Cognitive Impairment in Schizophrenia. First-generation Long-acting Antipsychotics versus Aripiprazole Long-acting Injectable News	0	394	March 13, 2019

Comparisons of the effects of second-generation antipsychotics long-acting injections on treatment retention according to severity of patient condition

Related topics